NO20021049L - Nye chalkoner - Google Patents

Nye chalkoner

Info

Publication number
NO20021049L
NO20021049L NO20021049A NO20021049A NO20021049L NO 20021049 L NO20021049 L NO 20021049L NO 20021049 A NO20021049 A NO 20021049A NO 20021049 A NO20021049 A NO 20021049A NO 20021049 L NO20021049 L NO 20021049L
Authority
NO
Norway
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Application number
NO20021049A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021049D0 (no
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20021049D0 publication Critical patent/NO20021049D0/no
Publication of NO20021049L publication Critical patent/NO20021049L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20021049A 1999-09-03 2002-03-01 Nye chalkoner NO20021049L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Publications (2)

Publication Number Publication Date
NO20021049D0 NO20021049D0 (no) 2002-03-01
NO20021049L true NO20021049L (no) 2002-05-03

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021049A NO20021049L (no) 1999-09-03 2002-03-01 Nye chalkoner

Country Status (21)

Country Link
US (1) US6620842B2 (pl)
EP (1) EP1212315B1 (pl)
JP (1) JP2003508527A (pl)
KR (1) KR100819576B1 (pl)
CN (1) CN1177843C (pl)
AT (1) ATE235483T1 (pl)
AU (1) AU776226B2 (pl)
CA (1) CA2382130A1 (pl)
CZ (1) CZ2002787A3 (pl)
DE (1) DE60001851T2 (pl)
DK (1) DK1212315T3 (pl)
ES (1) ES2193106T3 (pl)
GB (1) GB9920910D0 (pl)
HK (1) HK1043999B (pl)
HU (1) HUP0202579A3 (pl)
NO (1) NO20021049L (pl)
PL (1) PL353064A1 (pl)
PT (1) PT1212315E (pl)
RU (1) RU2252938C2 (pl)
SK (1) SK3112002A3 (pl)
WO (1) WO2001017988A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE471931T1 (de) 2002-04-17 2010-07-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
WO2004006865A2 (en) 2002-07-17 2004-01-22 Cytokinetics, Inc. Compounds, compositions, and methods
US6864264B1 (en) 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
CN104169267B (zh) * 2012-03-01 2017-03-01 香港理工大学 含炔烃的类黄酮、含叠氮化物的类黄酮和含三唑的类黄酮作为调节剂用于癌症的多药耐药

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2118321C1 (ru) * 1988-12-21 1998-08-27 Дзе Апджон Компани Замещенные бензопираноны и их фармацевтически приемлемые соли и гидраты
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
WO1991017749A1 (en) * 1990-05-17 1991-11-28 Baylor College Of Medicine Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
ES2193106T3 (es) 2003-11-01
RU2252938C2 (ru) 2005-05-27
PT1212315E (pt) 2003-08-29
HK1043999B (en) 2003-08-15
NO20021049D0 (no) 2002-03-01
DK1212315T3 (da) 2003-06-23
PL353064A1 (pl) 2003-10-06
AU776226B2 (en) 2004-09-02
CZ2002787A3 (cs) 2002-06-12
CA2382130A1 (en) 2001-03-15
EP1212315B1 (en) 2003-03-26
CN1371372A (zh) 2002-09-25
AU7510900A (en) 2001-04-10
ATE235483T1 (de) 2003-04-15
KR20020031598A (ko) 2002-05-02
GB9920910D0 (en) 1999-11-10
HK1043999A1 (en) 2002-10-04
WO2001017988A1 (en) 2001-03-15
HUP0202579A3 (en) 2003-07-28
EP1212315A1 (en) 2002-06-12
JP2003508527A (ja) 2003-03-04
CN1177843C (zh) 2004-12-01
SK3112002A3 (en) 2003-10-07
HUP0202579A2 (hu) 2002-11-28
US20030055056A1 (en) 2003-03-20
DE60001851D1 (de) 2003-04-30
US6620842B2 (en) 2003-09-16
KR100819576B1 (ko) 2008-04-22
DE60001851T2 (de) 2003-12-11

Similar Documents

Publication Publication Date Title
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
PL367682A1 (pl) Pochodne dolastatyny 10
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
ATE385797T1 (de) Phosphonatverbindungen
NO20012975L (no) Nye bifenyl og bifenylanaloge forbindelser som integrinantagonister
HUP0102879A2 (hu) Csontritkulás és klimaxos változások megelőzésére és/vagy kezelésére alkalmas készítmény
TR200002557T2 (tr) İntegrin reseptörü antagonistleri
YU596A (sh) Estrogen agonisti/antagonisti
BG105161A (en) Benzocycloheptenes, methods for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
ATE374609T1 (de) Synthese von 4-aminothalidomid enantiomeren
HN1997000052A (es) Nuevas 4(3h)--quinazolinas 2,3-disustituidas
NO20021050D0 (no) Nye derivater av flavoner, xantoner og kumariner
YU82702A (sh) Ortosupstituisani amidi antranilne kiseline i njihova primena kao sredstva za lečenje
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
AP2000001898A0 (en) Vitronectin receptor antagonists
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
PT989973E (pt) Calconas possuindo actividade antiproliferativa
NO20021049L (no) Nye chalkoner
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
EP1534284A4 (en) AMINO-SUBSTITUTED SULPHONANILIDES AND THEIR DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
ATE346036T1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
DE60113418D1 (de) Anti-karzinogene aktivität von aus der lakritzenwurzel isolierten hydroxylierten chalcon-verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application